Trump Says FDA Is Playing Politics With COVID-19 Vaccine

Henrietta Strickland
September 24, 2020

Peter Marks, director of the FDA's biologics office that oversees vaccines, said September 10 that the agency would put out guidelines for vaccine makers that will set a higher bar for emergency authorization.

President Donald Trump signaled that he could veto any tightening of USA rules for the emergency clearance of a coronavirus vaccine, a move that could increase concerns that the race to find a COVID-19 shot is being politicized ahead of the presidential election.

Robert Redfield's comments appeared to pour cold water on President Donald Trump's hopes the country could combat the virus with herd immunity, which experts have said would require anywhere from 60 to 80 of the entire population to contain antibodies for the novel coronavirus.

"That has to be approved by the White House", Trump said of the FDA guidance. "We may or may not approve it".

"President Trump is still trying to sabotage the work of our scientists and public health experts for his own political ends", Sen.

"These are dedicated men and women that are confronting the greatest public health crisis of our time, working 24/7, over 6700 of them involved in the outbreak itself, 1200 deploying, and it's offensive to me when I hear this type of comment".

Health officials have recently been engaged in a public relations battle to assure the public that political considerations will play no part in when vaccines receive approval. Fauci is among top officials testifying before the Senate Health, Education, Labour and Pensions committee on Wednesday.

But hours after the FDA chief's Senate appearance on Wednesday, Trump questioned the need for those updated guidelines at his press conference. "FDA will not permit any pressure from anyone to change that", Hahn said. "I don't see any reason why [a vaccine] should be delayed further because if they delay it a week or two weeks or three weeks, you know, that's a lot of lives you're talking about".

This story has been published from a wire agency feed without modifications to the text. Some of those studies could produce data on efficacy as soon as October.

Redfield didn't immediately expand on the prepared remarks, but a CDC report shows that weekly hospitalizations for all ages related to COVID-19 hit a second peak the week ending July 18. And there are signs that immune cells called T cells may also protect against the virus.

Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, said it is possible there are 50 million doses available by November, 100-plus million available by December and about 700 million available by January. Fauci said that no study has found evidence of such "cross immunity" from earlier exposure to other coronaviruses.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER